Effects of Ultrasound and Infrared on Joint Pain and Movement in Hemophilia A Patients.
Hemophilia A
Comparative Effects of Ultrasound and Infrared on Pain, Range of Motion and Joint Health in Knee, Elbow and Ankle Joints in Patients With Hemophilia A: a Randomized Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The study aims to compare the effectiveness of therapeutic ultrasound and infrared in managing hemarthrosis in patients with Hemophilia A, focusing on specific outcomes like joint pain, swelling, muscle atrophy, and range of motion.The main question to it is either one from both of the modalities are effective for hemophilia patients or not? comparison will be done to check the effectiveness of ultrasound and infrared on patients of both groups. participants will:
- 1.get the treatment according to their respective groups
- 2.Both groups were given 4 sessions for 4 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2024
CompletedFirst Submitted
Initial submission to the registry
October 30, 2024
CompletedFirst Posted
Study publicly available on registry
August 12, 2025
CompletedAugust 12, 2025
August 1, 2025
29 days
October 30, 2024
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
joint pain
Joint Pain: Measured using the Numerical Pain Rating Scale (NPRS) to quantify changes in pain severity. 0 indicates no pain while 10 indicates severe pain
3 weeks
ROM
Range of Motion (ROM): Measured using a goniometer to assess improvements in flexion and extension angles, measured in degrees, in the joint.
3 weeks
Swelling
Assessed based on circumference measurements around knee, elbow and ankle joint using inelastic tape measure in centimeters around the affected joint to detect reductions in swelling.
3 weeks
Study Arms (2)
ultrasound
EXPERIMENTALultrasound group containing 15 participants who were given ultrasound therapy for 10 minutes along with the conventional physiotherapy.
infrared radiation
EXPERIMENTALinfrared radiation group containing 15 participants who were treated with infrared therapy for 10 minutes along with the conventional physiotherapy.
Interventions
Ultrasound is a mechanical sound wave with frequencies above human hearing, requiring a medium like air or tissue to travel, commonly used in imaging.
Infrared, in contrast, is electromagnetic radiation associated with heat, doesn't need a medium, and is used in applications like thermal imaging and remote controls.
Eligibility Criteria
You may qualify if:
- Patients with hemophilia A (Eid \& Aly, 2015) .
- Who had the Bleeding frequency of atleast once per week (Eid \& Aly, 2015).
- Males with hemophilia A
- Irrespective of their therapeutic regime administered by their hematologists (Donoso-Úbeda, Meroño-Gallut, López-Pina, \& Cuesta Barriuso, 2020) .
You may not qualify if:
- Patients who had surgical procedures (Eid \& Aly, 2015) .
- Patients who were suffering from co-morbidities along with Hemophilia A.
- Patients who had any other disability/deformity.
- Who were receiving other physiotherapy treatment (Donoso-Úbeda et al., 2020) .
- Who failed to sign the informed consent (Donoso-Úbeda et al., 2020)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Danyal Ahmadlead
Study Sites (1)
Danyal Ahmad
Sialkot, Punjab Province, 51010, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- head supervior
Study Record Dates
First Submitted
October 30, 2024
First Posted
August 12, 2025
Study Start
March 1, 2024
Primary Completion
March 30, 2024
Study Completion
June 15, 2024
Last Updated
August 12, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share